Public-domain · open source
OpenJurist
← 659 FSUPP2D 279 - Bartlett v. MUTUAL PHARMACEUTICAL CO., INC.

Bartlett v. MUTUAL PHARMACEUTICAL CO., INC.’s Empirical Analysis

2009

Citation profile

19
cited by 19 later decisions
3
cited 3 times by the Supreme Court
March 2014
most recently cited

3 federal appellate · 9 district ·

Relationships

Applies 21 U.S.C. § 301 (Animal Drug Amendments of 1968) · 21 U.S.C. § 321 (Federal Food, Drug, and Cosmetic Act) · 21 U.S.C. § 352 (Federal Food, Drug, and Cosmetic Act) · 21 U.S.C. § 355 (Federal Food, Drug, and Cosmetic Act) · 21 U.S.C. § 356A (Federal Food, Drug, and Cosmetic Act) · 28 U.S.C. § 1332 (Class Action Fairness Act of 2005)

Relies on Skidmore v. Swift & Co. · Auer v. Robbins · Red Lion Broadcasting Co. v. Federal Communications Commission · Florida Lime & Avocado Growers, Inc. v. Paul · Christensen v. Harris County

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 19 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “the labeling proposed for the new drug is the same as the labeling approved for the [approved brand-name] drug.”
    2 later decisions quote this exact passage · from the dissent
  2. “introduction into interstate commerce [of] any new drug”
    2 later decisions quote this exact passage · from the majority
  3. “develop written procedures for the surveillance, receipt, evaluation, and reporting of postmarketing adverse drug experiences to FDA,”
    1 later decision quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.